Group 1 - The company held its 19th temporary board meeting on July 9, 2025, via telecommunication, with all 9 attending directors agreeing to waive the notice period due to urgency [1] - The board approved the appointment of Mr. Chen Yiqing as the secretary of the board, with a term lasting until the current board's term ends [1][2] - Mr. Chen Yiqing possesses the necessary qualifications and experience to fulfill the role of board secretary, having obtained the required training certification and meeting legal requirements [2] Group 2 - The company’s subsidiary, Beijing Zhongshan Jinqiao Biotechnology Co., Ltd., plans to donate a total of 3 million yuan, with 2 million yuan to the Peking Union Medical Foundation and 1 million yuan to the Beijing Red Cross Foundation, aimed at supporting public welfare projects [2] - This donation is part of the company's commitment to social responsibility and is expected to enhance its image and social influence [2] - The funds for the donation will come from the company's own resources and will not significantly impact its operational performance or harm the interests of shareholders, particularly minority shareholders [2]
中源协和: 中源协和细胞基因工程股份有限公司十一届十九次临时董事会会议决议公告